M3V — MeVis Medical Solutions AG Income Statement
0.000.00%
Last trade - 00:00
- €46.96m
- €39.21m
- €17.34m
- 96
- 61
- 46
- 80
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | GAS | GAS | GAS | GAS | GAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 18.1 | 17.1 | 16.2 | 18.8 | 17.3 |
Cost of Revenue | |||||
Gross Profit | 17.6 | 16.5 | 15.8 | 18 | 16.9 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 10.5 | 11.6 | 11.7 | 11.1 | 13.4 |
Operating Profit | 7.55 | 5.5 | 4.48 | 7.7 | 3.89 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 8.16 | 5.79 | 4.63 | 7.88 | 5.03 |
Provision for Income Taxes | |||||
Net Income After Taxes | 8.07 | 5.7 | 4.55 | 7.79 | 4.92 |
Net Income Before Extraordinary Items | |||||
Net Income | 8.07 | 5.7 | 4.55 | 7.79 | 4.92 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 8.07 | 5.7 | 4.55 | 7.79 | 4.92 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.43 | 3.13 | 2.5 | 4.28 | 2.7 |
Dividends per Share |